Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COMPLETE T2D Trial
2007-002150-39Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jun 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of insulin lispro protamine and insulin detemir in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Eli Lilly and Company. Primary endpoint: Change in hemoglobin A1c from baseline to 24 weeks. Started Jun 2007; status: completed.
02
Drugs
insulin lispro protamineinsulin detemir
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2007-002150-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002150-39.